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etter to the Editor
ibronectin  glomerulopathy  in a  88  year-old  male  with  acute
idney injury  on  chronic  kidney  disease:  A case  report  and  a
eview of  the  literature
lomerulopatía  ﬁbronectina  en  un  anciano  de  88  an˜os  de  edad  con
esión  renal  aguda  en  enfermedad  renal  crónica:  reporte  de  un  caso  y
aevisión  sistemática  de  la  literatur
ear Editor,
ibronectin glomerulopathy (FGP) was ﬁrst recognized
hrough direct staining in 1992 by Mazzucco et al.1 It was
egarded as a rare autosomal dominant disease that tends
o happen in various age groups and affects both sexes. The
linical features of this disease were proteinuria, typically
ephrotic range, microscopic hematuria, hypertension and
 slow decline in renal function.1–11 However, some patients
rogress to end-stage renal disease (ESRD) and dialysis has
een reported.5,12–14 Herein we reported a case of FGP that
as diagnosed based on the classic ultrastructural features
escribed above. This case was unique in that FGP presents
n a male who  was 88 years of age and has no known family
istory of FGP.
An 88-year-old gentleman was admitted with anuria
equiring dialysis for uremic encephalopathy and volume
verload. He had an extensive past medical history including
hronic renal failure (baseline Cr 200–240 mol/L) one month
go, hypertension, obstructive sleep apnea, mild cognitive
mpairment, query previous congestive heart failure, diastolic
ysfunction, COPD, macular degeneration, benign prostatic
ypertrophy and an anemia that was being investigated as an
utpatient. Baseline level of proteinuria was unknown. There
as no family history of kidney disease.
Relevant initial blood work included a serum creatinine
f 1148 mol/L, urea 82.2 mmol/L and potassium 5.7 mmol/L.
uring his stay in hospital, a 24-h urine collection was done
nd only 100 mL  of urine were collected with 100 mg  of pro-
ein and a protein excretion of 1 g/L. The other results of bloodPlease cite this article in press as: Cheng G, et al. Fibronectin glomerulopa
disease: A case report and a review of the literature. Nefrologia. 2016. http
xamination are as follows: a normal ESR, C3 and C4 values,
egative ANA, c-ANCA, p-ANCA, anti-GBM antibody, hepati-
is B and C serology, renal ultrasound showed normal sizeof the kidney. The extranuclear antigen screen was negative
except RNP. Immunoﬁxation revealed a serum IgG M-protein
with kappa light chain speciﬁcity. Bone marrow studies were
unremarkable.
A renal biopsy was performed and light microscopy showed
a lobular appearance with cellular mesangial nodules that
were expanded by matrix. There was also prominent arte-
riolar ﬁbrointimal hyperplasia and arteriolar hyalinosis. Congo
red staining was negative for amyloid. Immunostaining was
2+ for C3 in a granular pattern in the glomerular capillary
walls, however staining was negative for IgA, IgG, IgM, kappa,
lambda, albumin, ﬁbrin and C1. Electron microscopy showed
prominent expansion of the mesangial and subendothelial
regions with numerous randomly arranged ﬁbrils seen under
high power lens, measuring 10.7–16.8 nm in diameter. Poly-
clonal rabbit antibody (DAKO, A0245) was used in staining
of ﬁbronectin and there was positivity in the mesangium,
mesangial nodules and capillary walls (Fig. 1).
The patient received regular hemodialysis and other sup-
portive treatment including anti-hypertension, improving
anemia, and preventing renal osteopathy. Unfortunately, this
patient died of heart attack half a year later.
To our knowledge, most cases of FGP have presented and
been diagnosed in patients under 65-year-old. As this patient
was diagnosed with FGP at the age of 88, we  reviewed the
cases reported in literatures and attempted to explain how
this patient’s disease course ﬁts within our understanding
of FGP.
A PubMed search using the terms “ﬁbronectin glomeru-
lopathy” yielded 16 articles reports in English of patients withthy in a 88 year-old male with acute kidney injury on chronic kidney
://dx.doi.org/10.1016/j.nefro.2016.09.015
biopsy and ﬁbronectin staining proven FGP. This allowed us
to compare the disease features of 64 patients, including
the patient described in this paper (Table 1). These patients
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Table 1 – Reported cases of ﬁbronectin glomerulopathy.
Reporter No. Age at Bx Femal:male Hypertension Proteinuria
(g/24 h)
Micro-hematuria Cr (mol/l) Time of last
outcome
Last renal
outcome
Mazzucco et al. (1992)1 2 14, 33 2:0 NO 2 patients:
nephrotic
N/A  53,141 1 patient: 4 yr 1 patient: Cr was
stable
Strom et al. (1995)2 23 14–59 7:16 10 patients:
YES
8  patient: NO
21 patients:
positive
(9 patients:
nephritic)
12  patients:
positive
7  patients:
negative
45.8–137 1–15 yr 9 patients: Cr was
stable
4 patients: dialysis
4 patients:
transplant
4 patients: dead
1 patient: normal Cr,
renal cell carcinoma
Assmann et al. (1995)12 2 19, 46 0:2 1 patient: YES
1 patient: NO
2.8,6 N/A 76, 100 N/A N/A
Gemperle et al. (1996)13 9 20–46 3:6 8 patients:
YES
1 patient: NO
7 patients:
positive
(1 patient:
nephrotic)
N/A  N/A 6–21 yr 2 patients:
hemodalysis
2 patients: CAPD
3 patients: dead
Fujigaki et al. (1997)3 1 47 1:0 NO 1.4 NO 53 9 yr 0.82
Sato et al. (1998)15 1 23 0:1 YES 1–2 NO 80 N/A N/A
Niimi et al. (2002)4 1 3 0:1 YES >8 YES 80 7 yr Cr was stable
Castelletti et al. (2008)5 8 12–59 1:7 3 patients:
YES
4 patient: NO
6 patients:
positive
(4 patient:
nephrotic)
2  patients:
positive
1 patients:
negative
<194.5 2–23 yr 4 patients: Cr was
stable
2 patients: dialysis
1 patients:
transplant
1 patients: dead
1 patient: normal Cr,
renal cell carcinoma
Yong et al. (2009)6 1 41 0:1 YES Nephrotic N/A 150 10 mo 1.2
Brcic et al. (2010)7 1 34 0:1 YES 6 YES N/A 21 mo Cr was stable
Nadamuni et al. (2012)8 1 50 1:0 NO Nephrotic
range
YES 70.7 1 0.8
Otsuka et al. (2012)9 1 49 0:1 NO <0.5 g/d N/A 92 9 mo 1.54
Ertoy et al. (2013)10 1 24 0:1 NO 1 NO 72.5 16 mo
Ishimoto et al. (2013)14 1 78 1:0 YES Nephrotic
range
N/A 101 2 mo Dialysis
Yoshino et al. (2013)11 1 67 M YES 6 N/A 88.4 7 yr 3.54
Chen et al. (2015)16 10 19–46 4:6 4 patients:
YES
6 patient: NO
10 patients:
positive
(2 patient:
nephrotic)
4  patients:
positive
6 patients:
negative
47–312 N/A N/A
HTN: hypertension.
Bx: biopsy.
Note: If a particular piece of information was not available, the space is ﬁlled with “N/A”.
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eceived renal biopsy at the age of 3–88, which was a wide
ange. The majority of patients had proteinuria for more  than
 years before being diagnosed, which supported the idea
hat the onset of disease occurs at younger ages. Most of the
eported cases were patients in European countries, and there
ere several cases reported in Asia in recent years.
FGP is understood to present with nephrotic range protei-
uria and we  found 23 (35.9%) of the 64 cases that reported
roteinuria were nephrotic range. 21(32.8%) patients had
icrohematuria at the time of biopsy. Slightly more  than
alf of the cases had hypertension. There was no association
etween degree of proteinuria, microhematruia and hyperten-
ion. The degrees of renal impairment at the time of biopsy
ere variable. Most of them had slow decline in renal func-
ion. 22 (34.3%) patients’ serum creatinine was stable, and
4 (37.5%) patients progressed to ESRD or dead. What appears
ifferent was that our patient had severe renal impairment at
he time of his diagnosis.
In general, the timing of disease seems to be the distin-
uishing feature of our patient. Our patient had a history of
hronic kidney disease on the basis of hypertension, how-
ver he came to hospital with ESRD requiring dialysis and a
enal biopsy led to the discovery of FGP. With the usual di-
ease course of FGP being slowly progressive with proteinuria
f several years’ duration, it is possible that our patient had
GP and hypertensive kidney disease for many  years and that
 third insult may have precipitated ESRD. In his case it may
ave been the concomitant pneumonia.
In conclusion, FGP is an autosomal dominant disease that
as an indolent disease course after a typical presentation in
dulthood. Here we reported a case of FGP diagnosed in anPlease cite this article in press as: Cheng G, et al. Fibronectin glomerulopa
disease: A case report and a review of the literature. Nefrologia. 2016. http
8-year-old gentleman at the time of his progression to ESRD.
his may suggest that he had an exceptionally long indo-
ent course if the onset of disease was during middle age, or1
perhaps he had an atypically late onset of disease. Further
studies are needed to characterize the disease course in FGP
as well as the tendency of FGP to ESRD.
Yours sincerely,
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